Bladder Cancer
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.
August 16, 2024
Predictors of Early Continence After Single-port Transvesical Robot-assisted Radical Prostatectomy.
August 16, 2024
UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
August 15, 2024
Impact of diabetes mellitus on oncologic outcomes in patients receiving robot-assisted radical cystectomy for bladder cancer.
August 15, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis.
August 15, 2024
Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis.
August 15, 2024
Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit.
August 14, 2024
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
August 13, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.
August 12, 2024
Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females.
August 12, 2024
Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features.
August 9, 2024